Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations
Authors:
- Serge SicouriSSSerge Sicouri
- Aaron GlassAGAaron Glass
- Luiz BelardinelliLBLuiz Belardinelli
- Charles AntzelevitchCharles Antzelevitch
- 1 July 2008
- journal article
- Published by Elsevier in Heart Rhythm
- Vol. 5 (7) , 1019-1026
Abstract
No abstract availableKeywords
Funding Information
- National Heart, Lung, and Blood Institute
This publication has 31 references indexed in Scilit:
- Atrium-Selective Sodium Channel Block as a Strategy for Suppression of Atrial FibrillationCirculation, 2007
- Cellular basis for the electrocardiographic and arrhythmic manifestations of Timothy syndrome: Effects of ranolazineHeart Rhythm, 2007
- Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazineHeart, 2006
- Ranolazine Improves Abnormal Repolarization and Contraction in Left Ventricular Myocytes of Dogs with Heart Failure by Inhibiting Late Sodium CurrentJournal of Cardiovascular Electrophysiology, 2006
- Late‐Phase 3 EAD. A Unique Mechanism Contributing to Initiation of Atrial FibrillationPacing and Clinical Electrophysiology, 2006
- Atrial fibrillation: an epidemiologic, scientific and clinical challengeNature Clinical Practice Cardiovascular Medicine, 2005
- Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal AgentJournal of Cardiovascular Pharmacology and Therapeutics, 2004
- Mechanisms of Termination of Atrial Fibrillation by Class I Antiarrhythmic Drugs:Journal of Cardiovascular Electrophysiology, 2003
- The M Cell:Journal of Cardiovascular Electrophysiology, 1999
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989